Ac2-26 Improves Blood-Brain Barrier Integrity in Pneumococcal Meningitis
Author Information
Author(s): Deutloff Johannes, Pöhner Irina, Rößler Johann, Kipp Markus, Tauber Simone C., Brandenburg Lars-Ove
Primary Institution: Institute of Anatomy, Rostock University Medical Center
Hypothesis
Does the FPR ligand Ac2-26 influence the integrity of the blood-brain barrier during pneumococcal meningitis?
Conclusion
Ac2-26 treatment significantly prolongs blood-brain barrier integrity during pneumococcal meningitis in wild-type mice, but not in FPR2-deficient mice.
Supporting Evidence
- Ac2-26 treatment significantly prolonged the maintenance of blood-brain barrier integrity in wild-type mice.
- The effect of Ac2-26 was not observed in FPR2-deficient mice.
- Fibrinogen levels increased in the brain tissue during infection, indicating blood-brain barrier dysfunction.
Takeaway
This study shows that a special protein can help keep the brain's protective barrier strong when there's a serious infection.
Methodology
Mice were infected with Streptococcus pneumoniae and treated with Ac2-26; blood-brain barrier integrity was analyzed using immunohistochemistry and immunofluorescence.
Participant Demographics
Male wild-type and FPR-deficient mice were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website